£149.64

Springer Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)

Price data last checked 9 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£150 today · previous high £150 · all-time low £146

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical
Generating forecast…
£149.64 £145.98 £146.78 £147.58 £148.37 £149.17 £149.97 25 April 2026 15 May 2026 04 June 2026 24 June 2026 15 July 2026

Price Distribution

Price distribution over 82 days • 3 price levels

Days at Price
Current Price
8 days 39 days 35 days · current 0 10 20 29 39 £146 £148 £149 Days at Price

Price Analysis

Most common price: £148 (39 days, 47.6%)

Price range: £146 - £149

Price levels: 3 different prices over 82 days

Description

In this book, the classification of brain tumors is updated using magnetic resonance spectroscopy technology. The role of cellular immortality in brain tumors is reviewed. Genetic profiling and treatment (including neurosurgery) of brain cancers are explained. From the Back Cover The classification of brain tumors is up-dated using magnetic resonance spectroscopy technology. The role of cellular immortality in brain tumors is reviewed. Tumor to tumor metastases are a common occurrence; for example, , brain metastasis from breast cancer, lung cancer, and renal cancer is discussed. Genetic profiling and treatment (including neurosurgery) of such brain cancers are explained. Breast cancer patients treated with certain drugs (e.g., capecitabine and lapatinib can develop CNS tumors. Role of brain tumor suppressor genes (e.g., NRP/B gene) is pointed out. Biomarkers used to diagnose brain malignancies are explained in detail. A number of imaging modalities used for diagnosing and assessing the effectiveness of treatments of brain tumors are presented. The imaging methods discussed include MRI, PET, CT,  MRSi, and SPECT.  Also, is discussed the impact of PET using radiolabeled amino acids on brain tumors.

Product Specifications

Barcode

No barcode data available